Genmab A/S

NASDAQ: GMAB · Real-Time Price · USD
23.16
0.18 (0.78%)
At close: Aug 15, 2025, 3:11 PM

Genmab A/S Income Statement

Financials in DKK. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
21.53B 16.47B 14.6B 8.48B
Cost of Revenue
985M 226M n/a n/a
Gross Profit
20.54B 16.25B 14.6B 8.48B
Operating Income
6.7B 5.32B 6.27B 2.95B
Interest Income
995M 939M 324M 197M
Pretax Income
9.16B 5.64B 6.95B 3.92B
Net Income
7.84B 4.35B 5.45B 2.96B
Selling & General & Admin
3.79B 3.3B 2.68B 1.28B
Research & Development
9.75B 7.63B 5.56B 4.18B
Other Expenses
300M n/a n/a n/a
Operating Expenses
13.84B 10.93B 8.24B 5.46B
Interest Expense
120M 27M 21M 13M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
14.82B 11.15B 8.24B 5.46B
Income Tax Expense
1.32B 1.28B 1.49B 961M
Shares Outstanding (Basic)
646.34M 659.19M 653.87M 653.96M
Shares Outstanding (Diluted)
646.33M 659.15M 660.1M 660.46M
EPS (Basic)
12.14 6.60 8.34 4.52
EPS (Diluted)
12.14 6.60 8.26 4.48
EBITDA
9.7B 5.56B 7.35B 3.15B
EBIT
9.28B 5.71B 6.97B 3.93B
Depreciation & Amortization
413M 240M 362M 250M